Clinical Trials Browser

Carcinoma, Basal Cell × cemiplimab × 90 days × Clear all

NCT06981325 2026-03-11

CEMI-first

Phase 2 Recruiting

Carcinoma, Basal Cell, Skin Neoplasms

NCT03889912 2026-01-21

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Phase 1 Completed

Carcinoma, Basal Cell